Share on LinkedInShare on LinkedIn

ARTICLE · 24 APRIL 2017

CCI- Chemists And Druggists Associations Warned To Refrain From Indulging Into Anti-Competitive Practices

S.S. Rana & Co.
S.S. Rana & Co.
Contributor
S.S. Rana & Co.

S.S. Rana & Co.

Established in 1989, S.S. Rana & Co. is a premier intellectual property and corporate law firm...

View firm profile
Explore more from S.S. Rana & Co.

In 2009, the Belgaum District Chemists and Druggists Association filed a complaint alleging that Abbott India Ltd. and Geno Pharmaceuticals had stopped the supply of essential medicines.

IndiaAntitrust/Competition Law

In 2009, the Belgaum District Chemists and Druggists Association ('hereinafter referred as BCDA') filed a complaint alleging that Abbott India Ltd. and Geno Pharmaceuticals had stopped the supply of essential medicines. The sole ground for refusal by the Pharma Companies was that the members of the BCDA had to first obtain 'No objection certificate' from the All India organization of Chemists and Druggists ('hereinafter referred as AIOCD') or the Karnataka Chemists and Druggists Association ('hereinafter referred as KCDA') for being appointed as a stockist.

On 2nd March, 2017, the Competition Commission of India (hereinafter referred to as 'CCI') directed the KCDA to 'Cease and Desist' from indulging into the anti-competitive practice of mandating 'No Objection Certificate' as a prerequisite for appointment of stockist and also refrain from fixing 'trade margins' for retailers and wholesalers.1

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from